RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 98 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $2,948,000 | -66.9% | 1,041,612 | -58.6% | 0.02% | -71.1% |
| Q1 2018 | $8,917,000 | -8.8% | 2,518,882 | 0.0% | 0.08% | -10.6% |
| Q4 2017 | $9,773,000 | +52.8% | 2,518,882 | 0.0% | 0.08% | +63.5% |
| Q3 2017 | $6,398,000 | -7.0% | 2,518,882 | 0.0% | 0.05% | -13.3% |
| Q2 2017 | $6,877,000 | -17.5% | 2,518,882 | 0.0% | 0.06% | -11.8% |
| Q1 2017 | $8,337,000 | +73.5% | 2,518,882 | +24.8% | 0.07% | +44.7% |
| Q4 2016 | $4,805,000 | +276.9% | 2,018,882 | +465.2% | 0.05% | +327.3% |
| Q1 2015 | $1,275,000 | +16.5% | 357,187 | -25.9% | 0.01% | 0.0% |
| Q4 2014 | $1,094,000 | +17.0% | 481,972 | 0.0% | 0.01% | -8.3% |
| Q3 2014 | $935,000 | -46.6% | 481,972 | 0.0% | 0.01% | -42.9% |
| Q2 2014 | $1,750,000 | -6.4% | 481,972 | 0.0% | 0.02% | -12.5% |
| Q1 2014 | $1,870,000 | +31.2% | 481,972 | -3.6% | 0.02% | +20.0% |
| Q4 2013 | $1,425,000 | -20.4% | 500,000 | 0.0% | 0.02% | -20.0% |
| Q3 2013 | $1,790,000 | – | 500,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 4,500,000 | $11,925,000 | 4.90% |
| HealthInvest Partners AB | 1,090,000 | $2,889,000 | 4.07% |
| GREAT POINT PARTNERS LLC | 5,000,000 | $13,250,000 | 2.94% |
| CM Management, LLC | 775,000 | $2,054,000 | 1.55% |
| SECTOR GAMMA AS | 1,469,604 | $3,894,000 | 0.92% |
| Sio Capital Management, LLC | 913,621 | $2,421,000 | 0.73% |
| Telemetry Investments, L.L.C. | 190,000 | $504,000 | 0.65% |
| DAFNA Capital Management LLC | 879,000 | $2,329,000 | 0.59% |
| Rock Springs Capital Management LP | 4,860,200 | $12,880,000 | 0.30% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $4,074,000 | 0.27% |